344. BONUS Episode! Historic FDA Label Change!

THE WORLD IS CHANGING!!! Erasing fear with evidence, science and facts! This conversation delves into the significant impact of hormone replacement therapy (HRT) on women's health, particularly in the context of menopause. Dr. Rubin, Casperson and Makary discuss the recent FDA decision to remove black box warnings associated with HRT, which have perpetuated fear and misinformation for decades. They emphasize the importance of educating both clinicians and patients about the benefits and risks of HRT, highlighting the long-term health advantages it offers, such as reducing the risk of heart disease and osteoporosis. The discussion also addresses the need for informed consent and the importance of empowering women to make educated decisions about their health. Takeaways 50 to 70 million women have been denied health benefits from HRT. The FDA's removal of black box warnings is monumental. Misconceptions about HRT have persisted for decades. Education is crucial for both clinicians and patients. Hormone therapy can significantly reduce heart disease risk. Women often face barriers in accessing HRT. Informed consent is essential for women's health decisions. Long-term benefits of HRT include reduced risk of osteoporosis. The healthcare system needs to better address women's health issues. A collaborative approach is needed to improve women's health outcomes. FDA DIRECT podcast Dr. Makary's "Blind Spots" book To my fellow clinicians: listen to this podcast on ⁠⁠⁠Pinnacle for FREE to earn CME credit⁠⁠ Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices